Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006873-25Phase 4Completed
Phase 4, randomised, single-blind trial of macrogol (2 arms), sponsored by Norgine. Primary endpoint: Successful colon cleansing rate. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006873-25.